- Home
- BNTX vs DD Comparison
BNTX vs DD Comparison
Compare BNTX & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DD
- Stock Information
- Founded
- BNTX 2008
- DD 2015
- Country
- BNTX Germany
- DD United States
- Employees
- BNTX N/A
- DD N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DD Major Chemicals
- Sector
- BNTX Health Care
- DD Industrials
- Exchange
- BNTX Nasdaq
- DD Nasdaq
- Market Cap
- BNTX 26.4B
- DD 29.9B
- IPO Year
- BNTX 2019
- DD N/A
- Fundamental
- Price
- BNTX $110.02
- DD $75.54
- Analyst Decision
- BNTX Strong Buy
- DD Buy
- Analyst Count
- BNTX 18
- DD 13
- Target Price
- BNTX $140.27
- DD $86.54
- AVG Volume (30 Days)
- BNTX 575.8K
- DD 2.5M
- Earning Date
- BNTX 08-04-2025
- DD 07-30-2025
- Dividend Yield
- BNTX N/A
- DD 2.17%
- EPS Growth
- BNTX N/A
- DD N/A
- EPS
- BNTX N/A
- DD N/A
- Revenue
- BNTX $2,968,331,171.00
- DD $12,521,000,000.00
- Revenue This Year
- BNTX N/A
- DD $6.32
- Revenue Next Year
- BNTX $8.61
- DD $4.40
- P/E Ratio
- BNTX N/A
- DD N/A
- Revenue Growth
- BNTX 0.61
- DD 4.51
- 52 Week Low
- BNTX $76.53
- DD $53.77
- 52 Week High
- BNTX $131.49
- DD $90.06
- Technical
- Relative Strength Index (RSI)
- BNTX 53.75
- DD 65.72
- Support Level
- BNTX $108.72
- DD $72.67
- Resistance Level
- BNTX $112.58
- DD $75.90
- Average True Range (ATR)
- BNTX 2.62
- DD 1.68
- MACD
- BNTX -0.12
- DD 0.13
- Stochastic Oscillator
- BNTX 54.01
- DD 86.30
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025, which will be named Qnity.